Divis Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet

YOU ARE HERE > Moneycontrol > Markets > Announcements > Pharmaceuticals > Announcement - Divis Labs

Divis Labs

BSE: 532488

NSE: DIVISLAB

ISIN: INE361B01024

25th-Jan-2023 09:20Source: BSE

Divis Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

We are enclosing herewith the schedule of earnings conference call for Q3FY23 to be held on February 03, 2023.

More Announcements on:

25th-Jan-2023 10:31Source: NSE

25th-Jan-2023 09:20Source: BSE

Divis Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Board Meeting (Divis Labs)

Meeting Date

Remark

2023-02-03

Quarterly Results

OUR WINNING PICKS

DID YOU INVEST?

(August 06, 2018)

AT (Rs)

GAIN (Rs)

RECO PRICE

PEAK PRICE

Powerful mix of both trader and investor packs with timely expert advice.

Designed especially for traders looking to tap the profit opportunities of volatile markets.

For all investors looking to unearth stocks that are poised to move.